The same group of scientists who created an HPV vaccine is now responsible for the development of another cutting-edge vaccine, a product that is set to reduce cholesterol levels in blood vessels a lot better than common statins. The research was already released in the November issues of cardiology publications.
American researchers from several medical institutions worked together and created the latest vaccine that focuses on PCSK9’s organic processes, a protein that manages the cholesterol levels in the circulatory system. The medication is developed to block these types of proteins from doing their thing, thus decreasing the quantity of cholesterol that is linked to the blood vessels.
Statins are typically used by sufferers who have to reduce their cholesterol and prevent cardiac problems. But, these drugs are known for their adverse reactions, such as severe headaches, insomnia, muscle swelling, feeling sick and stomach pain. Around 15 million patients in the United States alone use statins during their treatment.
They are now the most generic drugs for regulating cholesterol levels. Even if they are efficient in many individuals, they still do have negative effects and do not have the same beneficial results for everyone, according to the doctors who were part in the creation of this vaccine. The outcomes of this therapy have been extremely satisfying and it could represent a highly potent method against high-cholesterol problems.
In the world of bad and good types of cholesterol, the blamed LDL is the negative element that should be kept under control. LDL is accumulated inside blood vessels, producing the obstructions in coronary heart affections. High LDL values put people at greater threat for cardiac arrest caused by blood clots in the arteries strangled by cholesterol problems.
Getting the LDL cholesterol levels measured helps evaluate the risks for cardiovascular diseases. If the values are high, regular treatments can reduce the danger of suffering a cardiac arrest. This vaccine has already been tested on lab rats and monkeys, and both revealed a 50% decrease in their LDL or bad cholesterol, as opposed to only 30% in improvements for the subjects that were treated with statins, as specialists have affirmed.
One of the more interesting elements about the new drug is that it appears to be a lot more efficient than treatments using statins alone. The scientists think that, because the new vaccine proved to be effective for animals testing, it could be good for people, too. but, they did not discuss further details about when they want to begin tests on humans.
Image source: NYCnews